Decreased angiogenin concentration in vitreous and serum in proliferative diabetic retinopathy

This publication has 41 references indexed in Scilit:

• HIF-1alpha and HIF-2alpha Are Differentially Activated in Distinct Cell Populations in Retinal Ischaemia
  PLOS ONE, 2010
• Glycemic Control Influences Serum Angiogenin Concentrations in Patients With Type 2 Diabetes
  Diabetes Care, 2010
• Digoxin inhibits retinal ischemia‐induced HIF‐1α expression and ocular neovascularization
  The FASEB Journal, 2010
• Ocular Angiogenesis
  2010
• Low Serum Angiogenin Concentrations in Patients With Type 2 Diabetes
  Diabetes Care, 2007
• Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons
  Human Molecular Genetics, 2007
• Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic Retinopathy
  Journal of Diabetes Research, 2007
• INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR PERSISTENT NEW VESSELS IN DIABETIC RETINOPATHY (IBEPE STUDY)
  Retina, 2006
• Anti‐VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases
  Annals of the New York Academy of Sciences, 2006
• Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
  Ophthalmology, 2006